Cytokinetics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $31,914 | $19,355 | $17,755 | $1,936 |
Gross Profit | 29,183 | 16,963 | 14,894 | -743 |
EBITDA | -195,131 | -169,318 | -180,170 | -277,177 |
EBIT | -198,762 | -172,696 | -183,031 | -279,856 |
Net Income | -198,762 | -206,031 | -183,031 | -306,178 |
Net Change In Cash | 31,914 | 19,355 | 17,755 | 1,936 |
Free Cash Flow | -164,174 | -151,387 | -148,294 | -116,859 |
Cash | 255,271 | 129,843 | 122,518 | 225,467 |
Basic Shares | 132,086 | 123,273 | 122,434 | 119,982 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $88,039 | $18,474 | $7,530 | $94,588 |
Gross Profit | 77,914 | -320,934 | -322,593 | -146,225 |
EBITDA | -774,830 | -493,483 | -456,684 | -331,985 |
EBIT | -784,955 | -503,014 | -468,576 | -337,799 |
Net Income | -784,955 | -589,526 | -526,244 | -388,955 |
Net Change In Cash | 88,039 | 18,474 | 7,530 | 94,588 |
Cost of Revenue | -45,484 | |||
Free Cash Flow | -534,816 | -399,796 | -415,749 | -310,851 |
Cash | 122,518 | 94,857 | 113,024 | 65,582 |
Basic Shares | 120,103 | 111,979 | 96,524 | 89,825 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.50 |
2026-03-31 | -$1.67 |
2025-12-31 | -$1.50 |
2025-09-30 | -$1.54 |